methylcellulose (OTC)

Brand and Other Names:Citrucel
  • Print

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

caplet

  • 500mg

powder

  • 2g/scoop

Constipation

2 caplets up to 6 times/day; not to exceed 12 caplets/day; follow each dose with 8 oz of water

Alternatively, 1 heaping tablespoon (2 g) in 8 oz water qDay to q8hr

Dosage Forms & Strengths

caplet

  • 500mg

powder

  • 2g/scoop

Constipation (6-11 Years Old)

<6 years

  • Safety & efficacy not established

6-12 years old

  • 1 caplet up to 6 times/day; not to exceed 6 caplets/day
  • 1 g (½ tablespoon) in 8 oz of cold water; may increase to 1 tablespoon q8hr

>12 years

  • 2 caplets up to 6 times/day; not to exceed 12 caplets/day; follow each dose with 8 oz of water
  • Alternatively, 1 heaping tablespoon (2 g) in 8 oz water qDay to q8hr
Next:

Interactions

Interaction Checker

and methylcellulose

No Results

     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            All Interactions Sort By:
             activity indicator 

            Contraindicated (0)

              Serious - Use Alternative (0)

                Monitor Closely (0)

                  Minor (1)

                  • sodium picosulfate

                    methylcellulose decreases effects of sodium picosulfate by Mechanism: unspecified interaction mechanism. Minor/Significance Unknown.

                  Previous
                  Next:

                  Adverse Effects

                  Frequency Not Defined

                  Flatulence

                  Impaction

                  Excessive bowel activity

                  Previous
                  Next:

                  Warnings

                  Contraindications

                  Hypersensitivity, bowel obstruction, symptoms of appendicitis or acute surgical abdomen, GI ulceration/adhesions, fecal impaction, dysphagia, rectal bleeding

                  Previous
                  Next:

                  Pregnancy & Lactation

                  Pregnancy Category: NA (supplement; not a drug)

                  Lactation: No data available; not absorbed, unlikely to pose risk in breastfeeding

                  Pregnancy Categories

                  A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

                  B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

                  C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

                  D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

                  X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

                  NA: Information not available.

                  Previous
                  Next:

                  Pharmacology

                  Mechanism of Action

                  Bulk producing laxative

                  Pharmacokinetics

                  Metabolism: Not absorbed from GI tract

                  Previous
                  Next:

                  Images

                  No images available for this drug.
                  Previous
                  Next:

                  Patient Handout

                  A Patient Handout is not currently available for this monograph.
                  Previous
                  Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.